| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 03/06/2001 | US6197794 Antiinflamamtory agents; immunology diseases |
| 03/06/2001 | US6197785 Cardiovascular disorders |
| 03/06/2001 | US6197783 Therapy for gastrointestinal disorders |
| 03/06/2001 | US6197782 Therapy for sexual disorders |
| 03/06/2001 | US6197778 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 03/06/2001 | US6197773 N-acyl and N-aroyl aralkyl amides as serotonergic agents |
| 03/06/2001 | US6197772 1- (1,2-disubstituted piperidinyl) -4-substituted piperazine derivatives |
| 03/06/2001 | US6197769 Serotonine receptors antagonist; gastrointestinal disorders, antiarrhythmia agents; incontinence |
| 03/06/2001 | US6197760 Isophosphoramide mustard analogs and use thereof |
| 03/06/2001 | US6197584 Antisense modulation of CD40 expression |
| 03/06/2001 | US6197581 Human adenylate cyclase and use therefor |
| 03/06/2001 | US6197566 α-galactosidase enzyme |
| 03/06/2001 | US6197519 Pancreas-derived serpin |
| 03/06/2001 | US6197341 Formulations of balsalazide and its derivatives |
| 03/06/2001 | US6197329 Anti-nausea compositions and methods |
| 03/06/2001 | US6197294 Cells containing recombinant polynucleotides coding for cell surface molecules that, when expressed in the cell, result in rejection of the cell by host cell by host immune system; useful for gene therapy |
| 03/06/2001 | US6197069 Adrenomedullin receptor polynucleotides |
| 03/01/2001 | WO2001014564A2 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
| 03/01/2001 | WO2001014557A1 Pd-1, a receptor for b7-4, and uses therefor |
| 03/01/2001 | WO2001014554A1 G protein-coupled receptor expressed in brain |
| 03/01/2001 | WO2001014548A2 New g-protein coupled receptor and dna sequences thereof |
| 03/01/2001 | WO2001014468A1 Alginate preparation and use of the same |
| 03/01/2001 | WO2001014418A2 p193 PROTEINS AND NUCLEIC ACIDS, AND USES THEREOF |
| 03/01/2001 | WO2001014372A2 Oxazole and thiazole derivatives as neurotrophin production/secretion promoting agent |
| 03/01/2001 | WO2001014371A1 N-heterocyclic derivatives as nos inhibitors |
| 03/01/2001 | WO2001014367A1 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 03/01/2001 | WO2001014342A1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments |
| 03/01/2001 | WO2001014333A1 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
| 03/01/2001 | WO2001014330A2 Phenylpiperazines as serotonin reuptake inhibitors |
| 03/01/2001 | WO2001014320A1 Compounds that inhibit tryptase activity |
| 03/01/2001 | WO2001014318A2 New effectors of dipeptidyl peptidase iv for topical use |
| 03/01/2001 | WO2001013957A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 03/01/2001 | WO2001013919A1 Ft-raman spectroscopic measurement of omeprazole isomer ratio in a composition |
| 03/01/2001 | WO2001013917A1 Npy antagonists: spiroisoquinolinone derivatives |
| 03/01/2001 | WO2001013916A1 Drugs inhibiting cell death |
| 03/01/2001 | WO2001013912A1 Remedies for liver regeneration of transplanted liver |
| 03/01/2001 | WO2001013906A2 Compositions including modafinil for treatment of eating disorders and for appetite stimulation |
| 03/01/2001 | WO2001013905A2 Methods for the treatment of mental and vascular disorders |
| 03/01/2001 | WO2001013897A1 Oral liquid compositions |
| 03/01/2001 | WO2001013886A1 Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent |
| 03/01/2001 | WO2000075365A3 COMPOUNDS AND METHODS TO ENHANCE rAAV TRANSDUCTION |
| 03/01/2001 | WO2000073449B1 Dna encoding snorf33 receptor |
| 03/01/2001 | WO2000072885A9 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 03/01/2001 | WO2000068209A3 1,5-benzodiazepine derivatives as cck-a receptor agonists |
| 03/01/2001 | DE19940740A1 Pharmazeutische Salze Pharmaceutical Salts |
| 03/01/2001 | DE19940130A1 Neue Effektoren der Dipeptidyl Peptidase IV zur topischen Anwendung New effectors of dipeptidyl peptidase IV for topical use |
| 03/01/2001 | DE19940011A1 Alginataufbereitung und deren Verwendung Alginataufbereitung and their use |
| 03/01/2001 | DE19939910A1 Neue Verbindungen, die Tryptase-Aktivität hemmen Novel compounds that inhibit tryptase activity |
| 03/01/2001 | CA2383456A1 Pd-1, a receptor for b7-4, and uses therefor |
| 03/01/2001 | CA2383371A1 P193 proteins and nucleic acids, and uses thereof |
| 03/01/2001 | CA2382867A1 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 03/01/2001 | CA2382838A1 Ft-raman spectroscopic measurement of omeprazole isomer ratio in a composition |
| 03/01/2001 | CA2382220A1 Compositions including modafinil for treatment of eating disorders and for appetite stimulation |
| 03/01/2001 | CA2382217A1 Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol and semiaqueous solvent therefor |
| 03/01/2001 | CA2382183A1 New g-protein coupled receptor and dna sequences thereof |
| 03/01/2001 | CA2382123A1 Novel polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
| 03/01/2001 | CA2381425A1 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 03/01/2001 | CA2381111A1 Npy antagonists: spiroisoquinolinone derivatives |
| 03/01/2001 | CA2381096A1 Compounds that inhibit tryptase activity |
| 03/01/2001 | CA2380513A1 Methods for treatment of mental disorders |
| 03/01/2001 | CA2379875A1 New effectors of dipeptidyl peptidase iv for topical use |
| 03/01/2001 | CA2376406A1 G protein-coupled receptor expressed in brain |
| 03/01/2001 | CA2376180A1 Oral liquid compositions |
| 02/28/2001 | EP1078631A1 Use of macrolide antibiotics for the treatment or prevention of coccidiosis |
| 02/28/2001 | EP1078629A2 Use of Salmeterol and salts for the treatment of inflammation and allergy |
| 02/28/2001 | EP1078628A2 Multiple unit tableted dosage form |
| 02/28/2001 | EP1078054A1 Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone |
| 02/28/2001 | EP1078006A1 Diagnosis and treatment of hepatic disorders |
| 02/28/2001 | EP1077994A1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same |
| 02/28/2001 | EP1077978A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 02/28/2001 | EP1077974A1 Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 02/28/2001 | EP1077971A1 1,5-DIARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS |
| 02/28/2001 | EP1077946A1 Fused tricyclic compounds which inhibit parp activity |
| 02/28/2001 | EP1077944A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity |
| 02/28/2001 | EP1077943A1 Heterocyclic inhibitors of p38 |
| 02/28/2001 | EP1077931A1 Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 02/28/2001 | EP1077928A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2001 | EP1077927A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2001 | EP1077912A1 Novel derivatives of 3,3-diphenylpropylamines |
| 02/28/2001 | EP1077728A1 Protection from ionizing irradiation or chemotherapeutic drug damage by in vivo gene therapy |
| 02/28/2001 | EP1077716A1 Method for the treatment of gastroesophageal reflux disease |
| 02/28/2001 | EP1077715A1 Use of rosmarinic acid and derivatives thereof as an immunosuppressant or an inhibitor of sh2-mediated process |
| 02/28/2001 | EP1077701A1 Anti-viral compounds |
| 02/28/2001 | EP1077694A1 Aryl nitrone therapeutics for the treatment of inflammatory bowel disease |
| 02/28/2001 | EP1077684A1 Effervescent preparations |
| 02/28/2001 | EP0799027B1 Liposomal interferon hybrid compositions |
| 02/28/2001 | CN1285874A Desaturase genes and their use |
| 02/28/2001 | CN1285828A Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom |
| 02/28/2001 | CN1285825A Novel allylthiopyridazine derivatives and process for preparing the same |
| 02/28/2001 | CN1285823A Phenyl-alkyl-imidazoles as H3 receptor antagonists |
| 02/28/2001 | CN1285822A H receptor ligands of phenyl-alkyl-imidazoles type |
| 02/28/2001 | CN1285821A Aryl Fused azapolycyclic compounds |
| 02/28/2001 | CN1285751A Antimutagenic compositions for treatment and prevention of photodamage to skin |
| 02/28/2001 | CN1285748A Use of 9-deoxy-2', 9-alpha-methano-3-oxa-4,5,6-trinor-3, 7-(1,'3'-interphenylene)-13, 14-dihydro-prostaglandin F, to treat peripheral vascular disease |
| 02/28/2001 | CN1285514A Medicine box bof testing anti-hepatitis C virus antibody |
| 02/28/2001 | CN1285356A Depeptide compound, its medical salt or ester, the medicinal composition using same as active component and the application for treating and preventing cell from dying |
| 02/28/2001 | CN1285220A Powder medicine made of Chinese and Western medicines for treating toothache and preparation process thereof |
| 02/28/2001 | CN1285219A Shengxuelongjing medicine for promoting the production of blood |
| 02/28/2001 | CN1285213A Chinese patent medicine for treating colitis and preparation process thereof |
| 02/28/2001 | CN1285209A Medicine for treating peptic ulcer |